je.st
news
Tag: elan
Elan to payback 20pc to shareholders
2013-03-04 09:43:38| Biotech - Topix.net
Irish drugmaker Elan said it will give shareholders 20 percent of the royalty rights for multiple sclerosis drug Tysabri in a bid to stave off an approach for the company by U.S. investment firm Royalty Pharma .
Tags: shareholders
payback
elan
20pc
Royalty Pharma offers to buy Elan for about $6.5B
2013-02-26 09:21:30| Biotech - Topix.net
Royalty Pharma said Monday that it wants to buy Elan for about $6.5 billion, but has yet to receive a formal response from the Irish drugmaker.
Tags: buy
offers
royalty
pharma
Elan to return $1Billion to shareholders
2013-02-22 10:04:55| Biotech - Topix.net
Irish drugmaker Elan will return $1 billion to shareholders and seek acquisitions with the proceeds of selling its stake in blockbuster multiple sclerosis treatment Tysabri to partner Biogen Idec.
Tags: return
shareholders
elan
1billion
Elan reorganises Tysabri revenues
2013-02-06 10:46:00| Biotech - Topix.net
Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug.
Tags: revenues
elan
tysabri
reorganises
Biogen Idec and Elan Submit Applications for First-Line Use of...
2013-01-16 12:20:28| Biotech - Topix.net
Today Biogen Idec and Elan Corporation, plc announced that they have submitted applications to the U.S. Food and Drug Administration and European Medicines Agency requesting updates to the TYSABRI labels.
Tags: of
use
submit
applications